World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
42573
World Ranking
12455
National Ranking
1169

Andrew R. Green publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Andrew R. Green sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 575 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Andrew R. Green D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Andrew R. Green sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Andrew R. Green is affiliated with the University of Nottingham in the United Kingdom. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, with a significant focus on Medicine. The subfields of study related to their work include Oncology, Cancer Research, Molecular Biology, Genetics, and Radiology, Nuclear Medicine and Imaging.

Their publication record reflects an emphasis on breast cancer, cancer genomics, and molecular pathways involved in cancer progression. Main topics covered in their research include Breast Cancer Treatment Studies, Cancer Genomics and Diagnostics, Cancer Cells and Metastasis, HER2/EGFR in Cancer Research, Cancer-related Molecular Pathways, Epigenetics and DNA Methylation, and DNA Repair Mechanisms.

Frequent co-authors collaborating with Andrew R. Green include:

  • Emad A. Rakha
  • Michael S. Toss
  • Ian O. Ellis
  • Nigel P. Mongan
  • Mansour Alsaleem

Publication venues with multiple articles from Andrew R. Green demonstrate a focus on oncology and cancer research disciplines. These venues are:

  • The Lancet
  • Breast Cancer Research and Treatment
  • Cancers
  • Histopathology
  • Cancer Research

Recent papers authored or co-authored by Andrew R. Green include:

  • "Human monkeypox - After 40 years, an unintended consequence of smallpox eradication" (2020) published in Vaccine
  • "IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis" (2020) published in Cancer Cell
  • "Breast tumor microenvironment structures are associated with genomic features and clinical outcome" (2022) published in Nature Genetics
  • "Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer" (2020) published in British Journal of Cancer
  • "Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival" (2020) published in Breast Cancer Research and Treatment

Best Publications

  • The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

    Christina Curtis;Christina Curtis;Sohrab P Shah;Suet-Feung Chin;Gulisa Turashvili

  • Prognostic markers in triple-negative breast cancer

    Emad A. Rakha;Maysa E. El-Sayed;Andrew R. Green;Andrew H. S. Lee

  • Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer

    Sahar M.A. Mahmoud;Emma Claire Paish;Desmond G. Powe;R. Douglas Macmillan

  • The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes

    Bernard Pereira;Suet Feung Chin;Oscar M. Rueda;Hans Kristian Moen Vollan

  • Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

    Fiona M. Blows;Kristy E. Driver;Marjanka K. Schmidt;Annegien Broeks

  • MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

    Cherie Blenkiron;Leonard D Goldstein;Natalie P Thorne;Inmaculada Spiteri

  • Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer

    Jack Cuzick;Mitch Dowsett;Silvia Pineda;Christopher Wale

  • Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes.

    Emad A. Rakha;Somaia E. Elsheikh;Somaia E. Elsheikh;Muhammed A. Aleskandarany;Muhammed A. Aleskandarany;Hany O. Habashi;Hany O. Habashi

  • Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome

    Somaia E. Elsheikh;Andrew R. Green;Emad A. Rakha;Des G. Powe

  • Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival.

    Desmond G. Powe;Melanie J. Voss;Kurt S. Zänker;Hany O. Habashy

  • The shaping and functional consequences of the microRNA landscape in breast cancer

    Heidi Dvinge;Anna Git;Stefan Gräf;Stefan Gräf;Mali Salmon-Divon;Mali Salmon-Divon

  • Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

    E A Rakha;T C Putti;D M Abd El-Rehim;C Paish

  • Biologic and Clinical Characteristics of Breast Cancer With Single Hormone Receptor–Positive Phenotype

    Emad A. Rakha;Maysa E. El-Sayed;Andrew R. Green;E. Claire Paish

  • High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer.

    Suet F Chin;Andrew E Teschendorff;John C Marioni;Yanzhong Wang

  • Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer.

    Emad A Rakha;Richard W G Boyce;Dalia Abd El-Rehim;Thomas Kurien

  • BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

    S.-J. Dawson;N. Makretsov;F. M. Blows;K. E. Driver

  • FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis

    Somaia Elbauomy Elsheikh;Andrew R Green;Maryou B K Lambros;Nicholas C Turner

  • Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups.

    Oscar M. Rueda;Stephen John Sammut;José A. Seoane;Suet-Feung Chin

  • A gene-expression signature to predict survival in breast cancer across independent data sets

    A Naderi;A E Teschendorff;N I Barbosa-Morais;N I Barbosa-Morais;Sarah Pinder

  • The prognostic significance of B lymphocytes in invasive carcinoma of the breast.

    S. M. A. Mahmoud;A. H. S. Lee;E. C. Paish;R. D. Macmillan

Frequent Co-Authors

Ian O. Ellis
Ian O. Ellis University of Nottingham
Emad A. Rakha
Emad A. Rakha University of Nottingham
Carlos Caldas
Carlos Caldas University of Cambridge
Ritu Aneja
Ritu Aneja University of Alabama at Birmingham
Jorge S. Reis-Filho
Jorge S. Reis-Filho Memorial Sloan Kettering Cancer Center
Jonathan M. Garibaldi
Jonathan M. Garibaldi University of Nottingham
John F.R. Robertson
John F.R. Robertson University of Nottingham
Julia Margaret Wendy Gee
Julia Margaret Wendy Gee Cardiff University
Sarah E Pinder
Sarah E Pinder King's College London
Justin Stebbing
Justin Stebbing Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens up diverse career opportunities beyond traditional clinical roles. Many students are exploring online degrees to enter specialized and in-demand healthcare fields. These online pathways provide flexibility, affordability, and a fast track to rewarding careers.

For those interested in mental health, online psych np programs offer advanced nursing education focused on psychiatric care. Graduates can pursue certification and make a significant impact in mental health services.

If managing healthcare systems appeals to you, consider earning a bachelors in health administration. This degree is an ideal starting point for a non-clinical healthcare career and is available through accredited online programs.

For those aiming higher, the cheapest online mha programs make it feasible to earn a master’s in healthcare administration and qualify for top-level management roles.

Nurses looking to advance further can benefit from the cheapest bsn to dnp programs, allowing for a direct path to a terminal practice degree online and greater leadership or clinical authority.

Best Scientists Citing Andrew R. Green

Trending Scientists

Recently Published Articles